Clinical Trial Update: HepATocellular Cancer Hcv Therapy Study [Phase 3]

View source ↗

Summary

Phase 3 trial for hepatocellular carcinoma/HCV therapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Hepatocellular Carcinoma
• Liver Cell Carcinoma

Snippet

Sponsor: Bayside Health | Conditions: Hepatocellular Carcinoma, Hepatoma | Phase 3 | Status: WITHDRAWN